Search results
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 24 hours agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 6 days agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
Covid Vaccine Side Effects: 4 Takeaways From Our Investigation
New York Times· 4 days agoThousands of Americans believe they experienced rare but serious side effects. Apoorva Mandavilli...
O.J. Simpson died from prostate cancer, not COVID-19 vaccine | Fact check
USA Today· 4 days agoAn April 13 Instagram post (direct link, archive link) shows an image of Dr. Anthony Fauci above an...
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
Market Watch· 1 day agoBioNTech swung to a net loss in the first quarter, when revenue plummeted after a sharp decline in its Covid-19 vaccine sales. The German ...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 5 days agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many ...
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 17 hours agoWe appointed a general manager in the U.S. who has commenced building out our commercial operations in the U.S. And we appointed further expertise in our...
COVID-19: What to know about the new variants; what are the symptoms of FLiRT?
WSB-TV 2 Atlanta· 21 hours agoA new group of COVID-19 variants are sparking concerns about a potential flare-up of the virus over...
As cholera cases rise worldwide, health officials sound 'concerning' alarm about vaccine shortages
Fox News via Yahoo News· 14 hours agoAs cholera continues to surge — and as vaccines remain in short supply — experts are warning about...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 5 days agoRevenues in the quarter were $167 million, beating the Zacks Consensus Estimate of $124.7 million....